| Financial Year |
March 31 2023 |
| Monetary Funds |
139,966,341.69 |
| Held-for-trading Financial Assets |
410,860,936.39 |
| Notes Receivable |
31,258,402.47 |
| Accounts Receivable |
256,947,499.40 |
| Advances to Suppliers |
5,484,025.88 |
| Other Receivables |
8,275,629.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
-- |
| Total Current Assets |
853,192,835.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,934,066.62 |
| Investment Properties |
1,244,133.54 |
| Fixed Assetes |
40,786,756.74 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,578,757.11 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,772,873.38 |
| Deferred Income Tax Assets |
39,632,566.94 |
| Other Non-Current Assets |
33,077,598.34 |
| Sub-Total of Non-Current Assets |
163,998,005.27 |
| Total Assets |
1,017,190,840.27 |
| Short-Term Loans |
18,900,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,483,211.43 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,633,625.24 |
| Taxes Payable |
4,989,454.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,824,841.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
13,872,935.46 |
| Other Current Liabilities |
6,283,881.90 |
| Sub-Total of Current Liabilities |
162,719,315.11 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,829,152.67 |
| Total Liabilities |
179,548,467.78 |
| Paid-In Capital(Or Share Stock) |
64,640,000.00 |
| Capital Surplus |
701,104,461.13 |
| Surplus Reserve |
22,172,769.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
49,618,670.98 |
| Minority Stockholder's Interest |
106,470.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
837,535,902.04 |
| Owner's Equity（Stockholder's Equity） |
837,642,372.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,017,190,840.27 |
